David Loiselle

Affiliations: 
2007- Pharmacology Duke University, Durham, NC 
Google:
"David Loiselle"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Woodford MR, Baker-Williams AJ, Sager RA, et al. (2021) The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect. Nature Structural & Molecular Biology. 28: 662-670
Smith AD, Garcia-Santamarina S, Ralle M, et al. (2021) Transcription factor-driven alternative localization of Cryptococcus neoformans superoxide dismutase. The Journal of Biological Chemistry. 100391
Dong B, Jaeger AM, Hughes PF, et al. (2020) Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1. Science Translational Medicine. 12
Sager RA, Woodford MR, Backe SJ, et al. (2019) Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90. Cell Reports. 26: 1344-1356.e5
Dushukyan N, Daneshvar M, Sager R, et al. (2018) PD46-11 PHOSPHORYLATION AND UBIQUITINATION REGULATE PROTEIN PHOSPHATASE-5 ACTIVITY AND ITS PROSURVIVAL ROLE IN KIDNEY CANCER Journal of Urology. 199
Dushukyan N, Dunn DM, Sager RA, et al. (2017) Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer. Cell Reports. 21: 1883-1895
Kulkarni MM, Ratcliff AN, Bhat M, et al. (2017) Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology. 14: 45
Crowe LB, Hughes PF, Alcorta DA, et al. (2017) A fluorescent Hsp90 probe demonstrates the unique association between extracellular Hsp90 and malignancy in vivo. Acs Chemical Biology
Woodford MR, Dunn DM, Blanden AR, et al. (2016) The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. Nature Communications. 7: 12037
Alwarawrah Y, Hughes P, Loiselle D, et al. (2016) Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer. Cell Chemical Biology
See more...